Clinical Trial Update: Allo-PBSCT as the First-line Treatment for Patients With the High-risk PTCL [NA]

View source ↗

Summary

A clinical trial is evaluating allogeneic peripheral blood stem cell transplantation as first-line therapy for high-risk peripheral T-cell lymphoma, with patien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Snippet

Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Conditions: Peripheral T Cell Lymphoma | NA | Status: RECRUITING